1.
|
Phase: Phase II, Phase I Type: Treatment Status: Completed Age: 16 to 80 Sponsor: Other Protocol IDs: CDR0000067172, CMMI-C-040A-98, CMMI-FDR001555, NCI-V99-1564, NCT00004048
|
|
2.
|
Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000067297, R35CA039841, CMMI-C-041A-98, NCI-H99-0039, NCI-V99-1568, NCT00004085
|
|
3.
|
Phase: Phase II, Phase I Type: Treatment Status: Completed Age: 18 to 80 Sponsor: NCI, Other Protocol IDs: CDR0000067299, R03CA077146, CMMI-C-039A-98, NCI-H99-0044, NCI-V99-1570, NCT00004177
|
|
4.
|
Phase: Phase II, Phase I Type: Treatment Status: Completed Age: 18 to 80 Sponsor: NCI, Other Protocol IDs: CDR0000067300, P01CA054425, CMMI-C-033-98, NCI-H99-0042, NCI-V99-1571, NCT00004087
|
|
5.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Closed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000068198, CMMI-C-047A-99, NCI-H00-0063, NCT00006458
|
|
6.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Closed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000068199, CMMI-C-057A-99, NCI-H00-0064, NCT00006347
|